Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
SEP 15816 image 1 LIV Hospital
Endometrial Cancer Icd 10: Amazing Scary C57.9 4

Diagnosis code C57.9 is a key ICD-10 code. It classifies malignant neoplasms of unspecified female genital organs. This code is important for keeping accurate medical records, for insurance, and in studies.

Diagnosing cancers in the female genital system can be tricky. This is because the exact site might not be known. The ICD-10 system, including codes like C57.9, helps doctors deal with these challenges.

We will look into how diagnosis code C57.9 is used in medical practice. We will also see its impact on patient care, focusing on female genital cancers.

Need the endometrial cancer icd 10 code C57.9? Discover amazing scary facts and find powerful, vital ways to manage essential health data.

Key Takeaways

  • Diagnosis code C57.9 refers to malignant neoplasms of unspecified female genital organs.
  • This code is vital for medical records and studies.
  • Accurate coding is key for good patient care and insurance.
  • C57.9 is part of the ICD-10 system used worldwide for health condition classification.
  • Understanding this code aids in diagnosing and managing female genital cancers.

Understanding ICD-10 Diagnosis Code C57.9

SEP 15816 image 2 LIV Hospital
Endometrial Cancer Icd 10: Amazing Scary C57.9 5

Code C57.9 in the ICD-10 system is for cancers in the female genital area, without a specific location. It helps doctors document and bill for female genital cancers when the exact location is unknown.

Definition and Classification in the ICD-10 System

The ICD-10 system helps code diseases, including cancers. Code C57.9 is for cancers in the female genital area without a specific location. It’s used when the exact location of the cancer is not known.

Anatomical Structures Covered Under C57.9

C57.9 covers cancers in the female genital area without a specific location. This includes cancers of the female reproductive system where the exact location is not known. Accurate coding is key for treatment and tracking.

Difference Between Benign and Malignant Neoplasm Codes

Benign neoplasms are non-cancerous and don’t spread. Malignant neoplasms are cancerous and can spread. The ICD-10 system codes these conditions differently. Code C57.9 is for malignant neoplasms.

Here’s a comparison between benign and malignant neoplasm characteristics:

Characteristics

Benign Neoplasms

Malignant Neoplasms

Growth Pattern

Slow, expansive growth

Rapid, invasive growth

Metastasis

No metastasis

Can metastasize, such as in cases of metastatic adenocarcinoma coded under specific ICD-10 codes

ICD-10 Coding

D codes (e.g., D25-D27)

C codes (e.g., C57.9 for unspecified female genital organs, or codes for icd10 metastatic cancer)

Understanding ICD-10 coding is key for accurate diagnosis and treatment planning.

In conclusion, ICD-10 diagnosis code C57.9 is important for cancers in the female genital area without a specific location. Accurate use of this code is vital for diagnosis, treatment, and billing.

Female Genital Cancers: Epidemiology and Classification

SEP 15816 image 3 LIV Hospital
Endometrial Cancer Icd 10: Amazing Scary C57.9 6

It’s key to understand the types and spread of female genital cancers. This knowledge helps in creating better ways to prevent and treat these diseases. These cancers impact different parts of the female reproductive system.

Global and US Prevalence Statistics

Female genital cancers are a big health issue worldwide. Cervical cancer is a major cause of new cancer cases every year. In the US, the types of these cancers differ by age. For example, cervical cancer icd10 coding is vital for tracking and managing it.

The high rate of these cancers globally shows we need better healthcare plans. The rates are affected by where you live and your access to healthcare.

Common Types of Female Reproductive Cancers

There are several types of female reproductive cancers, like cervical, ovarian, and uterine cancers. Each type needs its own ICD-10 coding for correct diagnosis and treatment. For instance, carcinoma cervix icd10 is for cervical cancer, and cervical adenocarcinoma icd10 is for a specific type.

Cancer ICD10 Coding Hierarchy for Gynecological Conditions

The ICD-10 coding for gynecological conditions is complex. It has many codes for different cancers and their stages. Knowing this hierarchy is essential for doctors to make accurate diagnoses and billing. It’s important to use the right codes, like for cervical cancer icd10 and other related conditions.

Learning the ICD-10 coding system helps doctors improve patient care. It also makes it easier to collect data for studies on cancer spread.

When C57.9 is Used in Clinical Practice

Diagnosis code C57.9 is key in clinical practice when the cancer’s exact location is unknown. It’s used when we’re not sure where the cancer started. More tests are needed to find out.

Diagnostic Challenges in Identifying Primary Cancer Sites

Finding the cancer’s starting point can be hard. The female reproductive system is complex, and symptoms can be similar. Sometimes, the cancer has spread, making it tough to pinpoint the origin. In these cases, C57.9 is used until we have more information.

Progression from Unspecified to Specific Diagnosis

As we learn more, a diagnosis can get more specific. For example, a patient might start with C57.9. But after more tests, like imaging and biopsies, we might find out it’s endometrial cancer (ICD-10 code C54.1). We update the records to show the most accurate diagnosis.

Documentation Requirements for Insurance and Medical Records

Keeping accurate records is vital for insurance and medical history. When we use C57.9, we make sure the records are complete. This includes test results, notes, and treatment plans. It helps us update the diagnosis as we learn more. For those with a history of endometrial cancer, we use hx of endometrial cancer icd10 or history of endometrial cancer icd10 to document their history.

Endometrial Cancer ICD10 Coding and Related Classifications

Knowing the ICD-10 codes for endometrial cancer is key for accurate medical records and billing. The ICD-10 system helps classify diseases, including cancers. It has specific codes for endometrial cancer, which healthcare providers need to know for proper care.

Specific Codes for Endometrial Cancer

Endometrial cancer is coded as C54.1 in the ICD-10 system. This code covers malignant neoplasm of the endometrium. The system also allows for detailed coding of cancer type and behavior. For example, C54.1 is often paired with morphology codes to identify cancer cell types.

History of Endometrial Cancer ICD10 Coding

The ICD-10 coding system has grown a lot over time. It has updated cancer classifications, including endometrial cancer. Knowing the history of these codes helps healthcare providers understand current coding practices.

Cervical Cancer ICD10 Codes and Subtypes

Cervical cancer is coded as C53 in the ICD-10 system. It distinguishes between squamous cell carcinoma and adenocarcinoma using specific codes. This is important for choosing the right treatment.

Ovarian Cancer ICD10 Classification

Ovarian cancer is coded as C56 in the ICD-10 system. It has specific codes for different subtypes and locations in the ovary. The icd10 for ovarian cancer is vital for diagnosis and treatment planning. A family history of ovarian cancer is also documented with specific ICD-10 codes (Z80.41), showing the role of genetics in cancer risk.

Understanding ICD-10 codes for endometrial and other gynecological cancers helps healthcare providers. It ensures accurate diagnosis, effective treatment, and complete patient care. The detailed nature of ICD-10 codes helps in better data collection and analysis, leading to improved cancer management.

Risk Factors for Female Genital Cancers

Female genital cancers come from genetics, environment, and lifestyle. Knowing these factors helps in prevention and early detection.

Genetic Predispositions Including BRCA Mutations

Genetics are key in some female genital cancers. BRCA1 and BRCA2 mutations raise the risk of ovarian and breast cancers. Genetic tests can spot these, leading to early action.

Family History of Ovarian Cancer ICD10 Considerations

A family history of ovarian cancer is a big risk. The ICD10 coding system helps track these cases. Knowing your family history guides screening and prevention.

Lifestyle, Environmental, and Medical Risk Factors

Lifestyle and environment also play a part. These include:

  • Age: Risk grows with age.
  • Reproductive History: Early menstruation, late menopause, and never having children raise risk.
  • Obesity: Being overweight or obese increases cancer risk.

HPV Infection and Cervical Adenocarcinoma ICD10

HPV is a big risk for cervical cancer, including cervical adenocarcinoma. The ICD10 coding for this is vital for treatment. HPV vaccine can lower cervical cancer risk.

Understanding and tackling these risks can lead to early detection and prevention. This improves outcomes for patients.

Recognizing Symptoms of Unspecified Female Genital Cancers

It’s important to know the symptoms of unspecified female genital cancers early. This helps in getting the right treatment quickly. We need to watch out for common signs and symptoms.

Common Warning Signs and Early Symptoms

Symptoms of these cancers can be hard to spot. They might include abnormal vaginal bleeding, pelvic pain, and unexplained weight loss. These signs can also show up in other health issues. So, it’s key to see a doctor for a check-up.

Other early signs might be changes in how you go to the bathroom or how you feel. These can mean the cancer is more advanced. It’s vital to tell your doctor about any odd feelings or changes.

Symptom Differences Among Various Gynecological Cancers

Each type of gynecological cancer has its own symptoms. For example, cervical cancer might show up as an abnormal Pap smear. Ovarian cancer could cause you to feel bloated or have stomach pain.

Table: Symptom Comparison Among Gynecological Cancers

Cancer Type

Common Symptoms

Cervical Cancer

Abnormal Pap smear, vaginal bleeding

Ovarian Cancer

Bloating, abdominal discomfort, pelvic pain

Endometrial Cancer

Postmenopausal bleeding, abnormal uterine bleeding

Importance of Regular GYN Exam ICD10 Screenings

Regular gynecological exams are key for catching these cancers early. These exams, listed under gyn exam icd10, can spot problems before they get worse. This makes treatment more effective.

Women should stick to their screening schedules. If you notice anything off, tell your doctor right away.

Diagnostic Procedures for Conditions Coded as C57.9

When a patient gets a C57.9 code, it means we need to find the cancer’s main site. This helps us decide the best treatment. Finding the cancer’s exact location and how far it has spread is key.

Initial Screening and Assessment Protocols

The first step is a detailed medical history and physical exam. This includes a pelvic exam. We also use imaging like ultrasound, CT scans, or MRI to see the pelvic organs and find any issues.

  • Pelvic examination to assess the reproductive organs
  • Imaging studies (ultrasound, CT, MRI) to visualize abnormalities
  • Laboratory tests, including tumor markers, to aid in diagnosis

Advanced Imaging and Biopsy Techniques

We might use PET scans to see how far the disease has spread. To confirm the diagnosis, we often do biopsies. These can be fine-needle aspiration or surgical biopsies.

Metastatic Adenocarcinoma ICD10 Differential Diagnosis

If metastatic adenocarcinoma is suspected, we need to figure out where it started. The ICD-10 codes help us do this.

Laboratory Markers and Genetic Testing

We use lab markers like CA-125 for ovarian cancer. Genetic tests, like BRCA1 and BRCA2, also help. These tests are important for diagnosing and managing C57.9 conditions.

Diagnostic Tool

Purpose

CA-125

Tumor marker for ovarian cancer

BRCA1 & BRCA2 Testing

Genetic testing for cancer risk assessment

PET Scan

Assess extent of disease and detect metastasis

By using all these diagnostic tools, we can accurately diagnose and manage C57.9 conditions. This helps improve patient care and outcomes.

Treatment Approaches for Unspecified Female Genital Cancers

Unspecified female genital cancers need a detailed treatment plan. This plan might include different treatments. The choice depends on the suspected cancer site, stage, and the patient’s health.

Surgical Interventions and Their Coding

Surgery is a key treatment for many female genital cancers. It aims to remove the tumor and affected tissues. Accurate coding, like ICD-10 for metastatic cancer, is vital for insurance and medical records.

  • Surgical Procedures: Procedures can include hysterectomy, salpingo-oophorectomy, and lymph node dissection.
  • Coding Considerations: Correct coding ensures that the patient’s records accurately reflect the diagnosis and treatment, facilitating better care and reimbursement.

Radiation and Chemotherapy Protocols

Radiation therapy and chemotherapy are also important treatments for unspecified female genital cancers. They can be used alone or with surgery.

  1. Radiation therapy targets cancer cells in specific areas, reducing tumor size.
  2. Chemotherapy uses drugs to kill cancer cells and is used when there’s a risk of cancer spread.

Targeted Therapies and Immunotherapy Options

Targeted therapies and immunotherapy are new ways to treat cancers, including female genital tract cancers. These treatments aim for precise targeting of cancer cells with fewer side effects.

Managing Treatment Side Effects and Complications

It’s important to manage cancer treatment side effects to keep the patient’s quality of life good. This includes physical symptoms and emotional and psychological support.

Effective treatment of unspecified female genital cancers needs a team effort. This includes surgery, radiation, chemotherapy, and newer therapies as needed. Accurate diagnosis coding, like ICD-10 for metastatic cancer, is key for guiding treatment and ensuring proper care.

Conclusion: Prognosis and Advances in Female Reproductive Cancer Care

Diagnosis and treatment have gotten better for many female reproductive cancers. It’s key to understand ICD-10 codes like C57.9 for female genital organs. This helps in accurate coding and better patient care.

There’s been a lot of progress in treating female genital cancers. Cancer icd10 coding has been a big help. Regular GYN exams and knowing risk factors are important for early detection.

Healthcare providers need to keep up with the latest in cancer care and coding. Our goal is to give top-notch care to patients worldwide. We aim to make a big difference in the lives of those with female reproductive cancers.

FAQ

What is diagnosis code C57.9?

Diagnosis code C57.9 is for cancers in the female genital area. It’s used when the exact location of the cancer isn’t known. This code is part of the ICD-10 system for health conditions.

What is the difference between benign and malignant neoplasm codes in the ICD-10 system?

In the ICD-10 system, benign neoplasms are different from malignant ones. Malignant neoplasms, like C57.9, are cancerous. They can spread and grow. Benign neoplasms are not cancerous and don’t spread.

What are the common types of female reproductive cancers and their ICD-10 coding hierarchy?

Female reproductive cancers include cervical, endometrial, and ovarian cancers. Each has its own ICD-10 code. They are organized in the ICD-10 system.

When is diagnosis code C57.9 used in clinical practice?

Code C57.9 is used when the cancer’s exact location in the female genital area is unknown. It’s used when finding the cancer’s site is hard.

What are the risk factors associated with female genital cancers?

Risk factors include genetic conditions like BRCA mutations and family history. Lifestyle and environmental factors also play a role. HPV infection is a big risk for cervical cancer.

What are the common warning signs and early symptoms of unspecified female genital cancers?

Symptoms vary but include abnormal bleeding and pelvic pain. Regular check-ups and screenings are key for early detection.

What diagnostic procedures are used for conditions coded as C57.9?

Procedures include initial screenings and advanced imaging like ultrasound. Biopsy and lab tests, including genetic testing, are also used.

What are the treatment approaches for unspecified female genital cancers?

Treatments include surgery, radiation, and chemotherapy. Targeted and immunotherapy options are also available, based on the cancer and patient’s health.

How is endometrial cancer coded in the ICD-10 system?

Endometrial cancer has specific ICD-10 codes. These codes are important for patient care and insurance.

What is the importance of regular GYN exams and screenings in detecting female genital cancers?

Regular GYN exams and screenings are key for early cancer detection. They help find cancers when they are easier to treat.

References

Medentic: https://www.medentic.app/en/resources/icd-codes/c57-9

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 510 67 91